| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/19/2004 | US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 10/19/2004 | US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 10/19/2004 | US6806270 Selective antagonists of A2B adenosine receptors |
| 10/19/2004 | US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent |
| 10/19/2004 | US6806063 Protein conjugate for use in the treatment of blood disorder |
| 10/14/2004 | WO2004087938A1 Novel physiologically active substances pf1270a, b and c |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087200A2 Vaccine and serum for protection of cystic fibrosis patients against pseudomonas aeruginosa |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087183A1 Method for the production of an extract of ivy leaves |
| 10/14/2004 | WO2004087151A1 Medicinal composition |
| 10/14/2004 | WO2004087150A1 Drug composition |
| 10/14/2004 | WO2004087149A1 Medicinal composition |
| 10/14/2004 | WO2004087148A1 Remedy and/or preventive for lung diseases |
| 10/14/2004 | WO2004087147A1 Remedy and/or preventive for lung diseases |
| 10/14/2004 | WO2004087142A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 10/14/2004 | WO2004087138A1 Method for treating vascular hyperpermeable disease |
| 10/14/2004 | WO2004087131A1 Antitussives |
| 10/14/2004 | WO2004071392A8 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 10/14/2004 | WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | WO2003065985A3 Uses of mammalian cytokine; related reagents |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen |
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204467 Use of 5HT3-receptor-antagonists |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204464 Isoxazoline compounds having MIF antagonist activity |
| 10/14/2004 | US20040204437 Substituted arylamine derivatives and methods of use |
| 10/14/2004 | US20040204425 Sodium channel blockers |
| 10/14/2004 | US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 10/14/2004 | US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204399 Aerosolized decongestants for the treatment of sinusitis |
| 10/14/2004 | US20040204369 Novel amide derivatives |
| 10/14/2004 | US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient |
| 10/14/2004 | US20040204355 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 10/14/2004 | CA2520957A1 Method for treating vascular hyperpermeable disease |
| 10/14/2004 | CA2520686A1 Therapeutic and/or preventive agent for pulmonary disease |
| 10/14/2004 | CA2520680A1 Antitussives |
| 10/14/2004 | CA2520577A1 Pharmaceutical composition |
| 10/13/2004 | EP1466641A1 Treatment of pulmonary vasoconstriction and asthma |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466602A1 Organ fibrosis inhibitors |
| 10/13/2004 | EP1466598A2 PDE-IV inhibitors |
| 10/13/2004 | EP1465926A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465916A2 Novel g proein-coupled receptor, gave7 |
| 10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465662A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465622A1 Use of ppar activators for the treatment of pulmonary fibrosis |
| 10/13/2004 | EP1465607A1 Pharmaceutical formulations with modified release |
| 10/13/2004 | EP1465603A1 Method of producing hollow, microporous particles which are intended, in particular, to be inhaled |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1208089B1 Diazocin-dione derivatives and their use as tryptase inhibitors |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/13/2004 | EP1206436B1 Retinoids for the treatment of emphysema |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | EP1202628B1 Novel hypoxanthine and thiohypoxanthine compounds |
| 10/13/2004 | EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 10/13/2004 | EP1185529B1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | CN1537117A 干扰素γ多肽变体 IFN-γ polypeptide variant |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537015A Stable liquid formulations of antibodies |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1535686A Slowly-released preparation containing loratadine and pseudoephedrine sulfate and its preparation method |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170582C Medicine composition for treating mouth and gingiva, gullet diseases |
| 10/13/2004 | CN1170552C FUjiu syrup for preventing and treating cough and asthma |
| 10/12/2004 | USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803364 Il-5 inhibiting 6-azauracil derivatives |
| 10/12/2004 | US6803361 Administering nucleotide sequence |
| 10/11/2004 | CA2423897A1 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |